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Abstract The interaction with human phagocytes is a hallmark
of symptomatic Neisseria gonorrhoeae infections. Gonococcal
outer membrane proteins of the Opa family induce the opsonin-
independent uptake of the bacteria that relies on CEACAM
receptors and an active signaling machinery of the phagocyte.
Here, we show that CEACAM receptor-mediated phagocytosis
of Opa52-expressing N. gonorrhoeae into human cells results in a
rapid activation of the acid sphingomyelinase. Inhibition of this
enzyme by imipramine or SR33557 abolishes opsonin-indepen-
dent internalization without affecting bacterial adherence.
Reconstitution of ceramide, the product of acid sphingomyelinase
activity, in imipramine- or SR33557-treated cells restores
internalization of the bacteria. Furthermore, we demonstrate
that CEACAM receptor-initiated stimulation of other signalling
molecules, in particular Src-like tyrosine kinases and Jun N-
terminal kinases, requires acid sphingomyelinase. These studies
provide evidence for a crucial role of the acid sphingomyelinase
for CEACAM receptor-initiated signalling events and inter-
nalization of Opa52-expressing N. gonorrhoeae into human
neutrophils. ß 2000 Federation of European Biochemical So-
cieties. Published by Elsevier Science B.V. All rights reserved.
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1. Introduction
Neisseria gonorrhoeae, the causative agent of the venereal
disease gonorrhea, is a highly adapted pathogen with only a
single natural host, man. During the course of symptomatic
infections, these bacteria are capable of interacting with a
variety of human cell types including epithelial cells and
phagocytes [1]. To accomplish the intimate attachment to dif-
ferent types of host cells, gonococci express a family of phase
variable outer membrane proteins, the so-called opacity-asso-
ciated or Opa proteins. Several studies have established that
particular Opa variants (Opa50, OpaA) mediate the binding of
the microorganisms to heparan sulfate proteoglycan receptors
on epithelial cells leading to the uptake of the bacteria by non-
phagocytic cells [2,3]. Internalization of these gonococcal
strains requires an activation of the cellular acid sphingomye-
linase [4], an enzyme which is able to induce the formation of
endocytic vesicles [5].
On the other hand, a distinct set of Opa proteins has been
shown to associate with members of the CEACAM receptor
family (formerly CD66 receptor family) on epithelial cells and
phagocytes [6^8]. In particular, Opa52, a representative of this
group of Opa proteins, recognizes CEACAM1 (CD66a, bili-
ary glycoprotein, BGP), CEACAM5 (CD66c, non-speci¢c
crossreacting antigen 90, NCA90) and CEACAM3 (CD66d,
CGM1) receptors, that are expressed on human neutrophils
[9]. Binding of Opa52-expressing bacteria to human phagocytic
cells triggers intracellular tyrosine phosphorylation of multiple
substrates that is dependent on the CEACAM receptor-medi-
ated activation of the Src-like tyrosine kinases Hck and Fgr
and the down-modulation of SHP-1 tyrosine phosphatase ac-
tivity [10,11]. In addition, Opa52-mediated interactions lead to
activation of the small GTPase Rac and the stress-activated
protein kinase JNK [10].
Since the signalling events triggered by Opa50-expressing
gonococci in epithelial cells and the engagement of CEACAM
receptors by Opa52-expressing bacteria ultimately lead to the
e⁄cient opsonin-independent uptake of the microorganisms,
we tested whether both pathways are interconnected. In the
present study we provide evidence for a requirement of the
acid sphingomyelinase for opsonin-independent internaliza-
tion of N. gonorrhoeae into human phagocytes. Infection of
the cells with Opa52-expressing N. gonorrhoeae results in a
rapid activation of the acid sphingomyelinase, Src-like tyro-
sine kinases and Jun-N-terminal kinases (JNK). Experiments
with pharmacological inhibitors of the acid sphingomyelinase
as well as of Src-like tyrosine kinases indicate that the acid
sphingomyelinase functions upstream of Src-like tyrosine ki-
nases and JNK activation.
2. Materials and methods
2.1. Cells, bacteria and infection
The human myelomonocytic cell line JOSK-M was cultured and
di¡erentiated in vitro as described [12]. As indicated, cells were pre-
incubated with imipramine (50 WM) for 15 min, SR33557 (10 WM) for
1 min or lavendustin (10 WM) for 30 min prior to infection. C16 cer-
amide (50 nM) dissolved in 0.01% octyl-glucopyranoside was added to
imipramine or SR33557-treated or untreated control cells 5 min prior
to infection. The gonococcal strains used in the present work are
exclusively derived from N. gonorrhoeae MS11 [13]. N280, a piliated
strain exhibiting the transparent phenotype (Opa3, P), as well as the
non-piliated strain N309 expressing a phagocyte-speci¢c Opa protein
(Opa52, P3) have been previously described [10]. Commensal Neisseria
cinerea (N340) was originally obtained from U. Berger, Heidelberg,
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Germany. All Neisseria were grown on GC-agar (Life Science Tech-
nologies) supplemented with vitamins and antibiotics, where appro-
priate, at 37‡C in 5% CO2 and subcultured daily. Recombinant Es-
cherichia coli DH5K producing Opa52 (H1907) and DH5K harboring
the empty expression vector pTrc99A (H1887) were maintained on
LB-plates supplemented with 100 Wg/ml ampicillin. For infection,
plate grown bacteria were suspended in RPMI1640, washed by cen-
trifugation at 4000 rpm for 5 min in a microcentrifuge and resus-
pended. The optical density at 550 nm (gonococci) or 600 nm (E.
coli) was determined in a DR2000 spectrophotometer (Hach, Cove-
land, CO, USA) and bacteria were added to di¡erentiated JOSK-M
cells in RPMI1640 supplemented with 5% heat inactivated FCS at a
ratio of 50 bacteria per cell at 37‡C to start the infection. After the
indicated time, cells were pelleted by centrifugation at 250Ug for
2 min at 4‡C (for immunoprecipitation) or the cells were washed
two times with PBS for 5 min at 100Ug in a microcentrifuge and
then centrifuged on glass coverslips for 5 min at 50Ug (for immuno-
£uorescence staining). Internalization was also determined by crystal
violet staining. To this end, cells were ¢xed for 15 min in 1% para-
formaldehyde in PBS, washed and stained for 12 h at 4‡C in 0.07%
crystal violet. Intracellular bacteria were microscopically identi¢ed
and counted from at least 100 cells.
2.2. Acid sphingomyelinase-activity
Infected or uninfected cells were lysed in 50 mM Tris (pH 7.4), 10
mM bacitracin, 1 mM benzamidine, 10 mM Na3VO4, 10 Wg/ml of
each aprotinin and leupeptin (A/L), 0.1 mg/ml soybean trypsin inhib-
itor and 0.2% Triton X-100 (lysis bu¡er), sonicated three times for 10
s each and centrifuged at 600Ug for 5 min. All samples were normal-
ized by labelling of the mammalian cells with [3H]thymidine for 24 h
prior to infection. An aliquot of the lysates was used to normalize for
equal amount of cells. The labelling method for normalization was
employed to avoid interference with proteins from the bacteria. An
equal amount of 50 mM Tris (pH 7.4), 3% NP40, 1% Triton X-100,
10 mM Na3VO4, 100 Wg/ml each A/L (lysis bu¡er) was added to the
supernatants and the acid sphingomyelinase was immunoprecipitated
for 5 h at 4‡C using a goat-anti-acid sphingomyelinase antiserum
immobilized on protein A/G agarose (Santa Cruz Biotechnology, San-
ta Cruz, CA, USA). Immunoprecipitates were washed three times
each in lysis bu¡er and 50 mM sodium acetate (pH 5.0), 0.2% Triton
X-100, 1 mM Na3VO4 and 10 Wg/ml each A/L and then incubated
with [14C]sphingomyelin (100 nCi/sample, 54.5 mCi/mmol; NEN-Du-
Pont) in 250 mM sodium acetate (pH 5.0), 1.3 mM EDTA, 0.05%
NP40 (assay bu¡er) at 37‡C for 30 min. Dried [14C]sphingomyelin was
solubilized by 10 min bath sonication in assay bu¡er. Samples were
¢nally extracted with CHCl3 :CH3OH (2:1, v/v) and H2O. The upper
phase was collected and the release of [14C]phosphorylcholine was
determined by liquid scintillation counting (LSC). Unspeci¢c immu-
noprecipitates were performed with an irrelevant antibody. Those
samples display a low background of 80^100 cpm compared to
2000^4000 cpm in the speci¢c samples, which is probably due to
some contamination during the extraction procedure.
2.3. Immuno£uorescence microscopy
Infected cells were centrifuged onto glass coverslips in 24-well plates
(Nunc, Roskilde, Denmark) and ¢xed for 20 min in 3% paraformal-
dehyde in PBS at room temperature. After three washes with PBS,
cells were permeabilized for 5 min in PBS supplemented with 10%
fetal calf serum and 0.2% saponin (blocking bu¡er). Suitable dilutions
of polyclonal rabbit-anti-N. gonorrhoeae MS11 (AK92) and monoclo-
nal mouse-anti-human lysosome-associated membrane protein 2 (h-
lamp-2; clone H4B4; DSHB, University of Iowa, IA, USA) in block-
ing bu¡er were applied to the samples for 1 h at room temperature.
Cells were washed twice with PBS, blocked again for 5 min and in-
cubated with FITC-conjugated goat-anti-rabbit and Texas Red-con-
jugated goat-anti-mouse-antibodies (Dianova, Hamburg, Germany)
for 45 min at room temperature. After three washes, coverslips were
mounted in glycerol medium, sealed with nail polish, and viewed with
a Leica TCS 4D confocal laser scanning microscope equipped with an
argon^krypton mixed gas laser (Leica Lasertechnik, Heidelberg, Ger-
many). Images were taken serially using appropriate excitation and
emission ¢lters for the £uorescent dyes. The corresponding images
were digitally processed with Photoshop 4.0 (Adobe Systems, Moun-
tain View, CA, USA) and merged to yield pseudocolored RGB pic-
tures. Intracellular bacteria were detected by their co-localization with
the phagosomal/lysosomal membrane protein h-lamp-2 and the per-
centage of infected cells was determined by counting at least 200 cells
in each of three independent infections.
2.4. Src-like tyrosine kinase-assays
The activity of Src-like tyrosine kinases was determined by in vitro
kinase autophosphorylation assays. To this end, cells were infected for
the indicated time or left uninfected, lysed in 25 mM HEPES (pH 7.4),
0.1% SDS, 0.5% sodium deoxycholate, 1% Triton X-100, 125 mM
NaCl, 10 mM each NaF, Na3VO4 and sodium pyrophosphate and
10 Wg/ml of each aprotinin and leupeptin (A/L) (RIPA bu¡er), cen-
trifuged and kinases Hck or Fgr, respectively, were immunoprecipi-
tated from the supernatants using a⁄nity puri¢ed rabbit anti-Hck or
anti-Fgr antibodies (Santa Cruz Biotechnology). Immunoprecipitates
were incubated at 4‡C for 4 h, washed three times in RIPA bu¡er and
three times in Src-kinase bu¡er (25 mM HEPES (pH 7.0), 150 mM
NaCl, 10 mM MnCl2, 1 mM Na3VO4, 5 mM DTT and 0.5% NP-40).
Samples were resuspended in 40 Wl Src-kinase bu¡er. The reaction was
initiated by addition of 10 WCi [Q-32P]ATP (NEN/Du-Pont, Bad Hom-
burg, Germany; 3000 Ci/mmol) and ATP (10 WM) in Src-kinase bu¡-
er. The samples were incubated at 30‡C for 20 min, the reaction was
stopped with 8 Wl of reducing 5USDS sample bu¡er and SDS^PAGE
was performed followed by autoradiography. An aliquot of the im-
munoprecipitates was analyzed by Western blotting for the amount of
kinase in the immunoprecipitates.
2.5. JNK-1 activity
To measure the activity of JNK-1, cells were lysed in RIPA-bu¡er
and the lysates were cleared by centrifugation at 25 000Ug for 20 min.
JNK-1 was immunoprecipitated from the supernatant at 4‡C for 4 h
using a⁄nity puri¢ed rabbit anti-human JNK-1 antibodies (Santa
Cruz Biotechnology). Immunocomplexes were immobilized on protein
A/G for additional 60 min at 4‡C, washed twice in RIPA-bu¡er, twice
in 20 mM HEPES, 132 mM NaCl, 5 mM KCl, 1 mM CaCl2, 0.7 mM
MgCl2, 0.8 mM MgSO4, 1% NP-40, 2 mM Na3VO4, once in 100 mM
Tris (pH 7.5), 0.5 M LiCl and ¢nally twice in JNK kinase bu¡er (12.5
mM MOPS (pH 7.5), 12.5 mM L-glycerophosphate, 0.5 mM EGTA,
7.5 mM MgCl2, 0.5 mM NaF, 0.5 mM Na3VO4). After washing, the
immunoprecipitates were resuspended in JNK-kinase bu¡er supple-
mented with 10 WCi [Q-32P]ATP (6000 Ci/mmol, NEN/DuPont), 10
WM ATP and 1 mg/ml GST-c-jun (amino acids 1^79). The samples
were incubated at 30‡C for 15 min, stopped by addition of 5 Wl boiling
5U reducing SDS-sample bu¡er. Samples were separated by 10%
SDS^PAGE and electrophoretically transferred to PVDF membranes.
Following autoradiography, the membranes were analyzed for equal
amounts of immunoprecipitated kinase by probing with polyclonal
JNK-1 antibodies.
3. Results
The present study aimed to de¢ne the interplay between the
acid sphingomyelinase and Src-like tyrosine kinases, both
have been previously shown to be crucial for the internaliza-
tion of N. gonorrhoeae by human epithelial cells or Opa52-
expressing gonococci by phagocytic cells, respectively [4,10].
In order to investigate the role of the acid sphingomyelinase
and Src-like tyrosine kinases in opsonin-independent phago-
cytosis, we infected in vitro di¡erentiated human phagocytic
cells with N. gonorrhoeae and determined the activity of the
acid sphingomyelinase following immunoprecipitation of the
enzyme (Fig. 1). The infection of JOSK-M cells with the
Opa52-expressing, non-piliated strain N309 resulted in a very
rapid, approximately 1.5-fold activation of the acid sphingo-
myelinase. Acid sphingomyelinase activity in response to
N309 peaked already 15 min after infection and declined to
a baseline level within the following 45 min. In contrast, in-
fection with the non-opaque, piliated strain N280 had no
e¡ect on cellular acid sphingomyelinase activity (Fig. 1). Like-
wise, infection with non-pathogenic N. cinerea (N340) did not
stimulate this enzyme. Since activation of the acid sphingo-
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myelinase was restricted to N. gonorrhoeae expressing Opa52,
we wondered whether expression of this Opa protein is su⁄-
cient to induce acid sphingomyelinase in target cells. There-
fore, JOSK-M cells were infected with a strain of E. coli ex-
pressing Opa52 (H1907) or a control strain (H1887). Only
Opa52-expressing bacteria enhanced acid sphingomyelinase ac-
tivity, whereas the control strain did not lead to a stimulation
(Fig. 1).
The rapid activation of the acid sphingomyelinase suggest
that stimulation of this enzyme plays a role in the early phase
of CEACAM receptor signalling. To gain some insight into
the potential role of the acid sphingomyelinase for the uptake
process we tested the e¡ect of two acid sphingomyelinase in-
hibitors, imipramine [14] and SR33557 [15], on N. gonorrhoeae
N309 internalization by JOSK-M cells. Acid sphingomyeli-
nase was almost completely inhibited by 15 min pre-incuba-
tion of the cells with 50 WM imipramine previously shown to
trigger a degradation of acid sphingomyelinase [14]. SR33557
(10 WM) blocked acid sphingomyelinase activity within 30^60
s after application without signi¢cant degradation at the 75-
or 72-kDa isoforms of ASM (not shown).
Sphingomyelinase inhibition was determined by immuno-
precipitation of the enzyme and measurement of the enzyme
activity in the precipitates revealed an approximately 80^90%
inhibition of sphingomyelinase activity by 50 WM imipramine
or 10 WM SR33557 (Fig. 2A). Acid sphingomyelinase inhibi-
tion correlated with a dose-dependent inhibition of N. gonor-
rhoeae N309 uptake (Fig. 2B). Compared to untreated control
Fig. 1. Infection of human phagocytes with Opa52-expressing N.
gonorrhoeae activates the acid sphingomyelinase. Human phagocytic
cells were infected with the Opa52-positive N. gonorrhoeae N309, the
Opa-negative N280, non-pathogenic N. cinerea N340 as well as E.
coli transfected with an expression vector for Opa52 or a control
vector for the indicated time. After infection, cells were lysed, the
acid sphingomyelinase was immunoprecipitated and the activity of
the enzyme was determined by consumption of [14C]sphingomyelin.
Activity is expressed as mmol sphingomyelin consumption/mg (total
protein) h. The non-speci¢c immunoprecipitation (n.s.) was per-
formed with an irrelevant antibody after infection of phagocytic
cells with N309 for 30 min and contained no signi¢cant sphingo-
myelinase activity. The results indicate a speci¢c activation of the
acid sphingomyelinase by the Opa expressing bacteria, whereas N.
gonorrhoeae or E. coli lacking Opa proteins fail to stimulate the
acid sphingomyelinase. The bars represent the means þ standard de-
viation of three independent experiments with duplicate samples.
Fig. 2. Inhibition of the acid sphingomyelinase prevents N. gonor-
rhoeae invasion into, but not adhesion to human phagocytes. A: In-
cubation of human phagocytes with imipramine for 15 min or
SR33557 for 1 min results in inhibition of the acid sphingomyeli-
nase. The cells were pre-treated for 15 min with 50 WM imipramine
(Imi), for 1 min with 10 WM SR33557 (SR) or solvent only (3), in-
fected with N309 for 15 min and the activity of the acid sphingo-
myelinase in uninfected or infected cells was determined as described
in Fig. 1. Bars represent the means þ standard deviation of two ex-
periments performed in duplicate. B: The inhibition of the acid
sphingomyelinase activity by imipramine or SR33557 results in a
dose-dependent inhibition of N. gonorrhoeae N309 internalization
into human phagocytic cells. JOSK-M cells were pre-treated with
the indicated concentrations of imipramine or SR33557 and infected
with N309. The percentage of infected cells was determined by co-
staining of bacteria and the phagosomal membrane marker h-lamp-
2. Bars indicate the means þ standard deviation of three independent
experiments. C: The block of bacterial internalization upon inhibi-
tion of the acid sphingomyelinase is not due to an altered adhesion
of the bacteria to the cells as revealed by confocal microscopy ex-
periments. The samples were simultaneously stained with antibodies
directed against N. gonorrhoeae (middle row, green in the overlay)
and antibodies recognizing human lysosome associated membrane
protein 2 (h-lamp-2) (left row, red in the overlay). The overlays
show that under standard conditions Opa52-expressing N. gonor-
rhoeae are taken up e⁄ciently as evidenced by co-localization with
the intracellular marker h-lamp-2. In contrast, in cells pretreated
with imipramine N. gonorrhoeae still bind to the phagocytes, but
fail to be internalized. D: Addition of 50 nM C16 ceramide 5 min
prior to infection of cells treated with imipramine or SR33557, re-
stores internalization of N. gonorrhoeae N309 into those cells.
JOSK-M cells were treated for 15 min with 50 WM imipramine or
for 1 min with 10 WM SR33557 or left untreated. C16 ceramide was
added 10 min after addition of imipramine as indicated or 1 min
after SR33557 and after further 5 min incubation the infection was
initiated as above. Cells were infected for 15 min, ¢xed, crystal vio-
let-stained and internalization of the bacteria was determined by an-
alyzing at least 100 cells using a Nikon Optiphot microscope.
Shown are the means þ standard deviation of two independent ex-
periments.
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cells there was a more than 4^5 fold reduction of bacterial
internalization in cells pre-incubated with imipramine or
SR33557. Interestingly, cells treated with imipramine or
SR33557 still bound Opa52-expressing gonococci, but failed
to internalize the bacteria, whereas control cells took up the
pathogens into an intracellular vesicular compartment charac-
terized by h-lamp-2 molecules (Fig. 2C and not shown).
In order to exclude that imipramine or SR33557 blocked N.
gonorrhoeae internalization by inhibition of other molecules
than acid sphingomyelinase, we added 50 nM C16 ceramide to
imipramine or SR33557-treated or untreated cells 5 min prior
to infection with N. gonorrhoeae N309 (Fig. 2D). Experiments
employing [14C16]ceramide (sphingoid base: sphingosine) indi-
cate that approximately 5% of the ceramide is incorporated
into the cells and not further metabolized during the short, 5-
min incubation time (not shown). Since acid sphingomyelinase
metabolizes sphingomyelin to ceramide, the addition of C16
ceramide should speci¢cally restore the function of acid sphin-
gomyelinase in imipramine or SR33557-treated cells without
reconstitution of other enzymes potentially targeted by imi-
Fig. 2 (continued).
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pramine or SR33557. The results of these studies reveal that
addition of acid sphingomyelinase to imipramine-treated cells
completely restores internalization of N. gonorrhoeae correlat-
ing with a signi¢cant ASM activity in those cells (Fig. 2D).
Taken together, these results suggest a crucial role for the
acid sphingomyelinase in CEACAM receptor-mediated
phagocytosis by human phagocytic cells.
Next, we tested the consequence of acid sphingomyelinase
inhibition for other signaling molecules during the uptake
process. In particular, we tested whether the acid sphingomye-
linase might be involved in the activation of the Src-like ty-
rosine kinases Hck and Fgr upon internalization of Opa52-
expressing N. gonorrhoeae N309. These kinases have been
previously shown to be activated by and required for the
CEACAM receptor-mediated opsonin-independent phagocy-
tosis of N. gonorrhoeae by human phagocytic cells [10]. To
this end, we determined the activity of Src-like tyrosine ki-
nases upon infection with N. gonorrhoeae N309 in cells pre-
treated with imipramine or left untreated (Fig. 3A). The re-
sults demonstrate that the acid sphingomyelinase inhibitor
imipramine almost completely prevented the activation of
the Src-like tyrosine kinases Hck and Fgr upon infection of
JOSK-M cells with N. gonorrhoeae N309 (Fig. 3A). In addi-
tion, we investigated if the inhibition of acid sphingomyelinase
by imipramine a¡ects additional signalling events stimulated
during CEACAM receptor-mediated uptake of Opa52-express-
ing N. gonorrhoeae. Therefore, JOSK-M cells pre-treated or
not for 15 min with 50 WM imipramine were infected with N.
gonorrhoeae N309 or non-pathogenic N. cinerea and JNK
activity was determined. As shown in Fig. 3B, infection of
the phagocytic cells with N309 stimulated a pronounced in-
duction of JNK activity, whereas imipramine pre-treatment
abolished the increase in JNK activity.
To further investigate the interaction of the acid sphingo-
myelinase and protein tyrosine kinases we inhibited Src-like
tyrosine kinases using lavendustin and determined the activity
of the acid sphingomyelinase in those cells. In contrast to the
experiments using imipramine, an inhibition of Src-like tyro-
sine kinases using lavendustin did not a¡ect the stimulation of
the acid sphingomyelinase by N. gonorrhoeae N309 (Fig. 3C)
suggesting that the acid sphingomyelinase functions upstream
of Src-like tyrosine kinases in the internalization process.
Fig. 2 (continued).
Fig. 3. Inhibition of the acid sphingomyelinase prevents N. gonor-
rhoeae induced activation of Src-like tyrosine kinases and JNK.
A,B: Human JOSK-M cells were pretreated for 15 min with 50 WM
imipramine or solvent only, infected for the indicated time with N.
gonorrhoeae N309 or non-pathogenic bacteria, lysed and the Src-like
tyrosine kinases Hck and Fgr (A) or JNK (B) were immunoprecipi-
tated. The activity of the kinases was determined by autophosphory-
lation in the presence of [Q-32P]ATP (A) or by incubation with the
substrate GST-c-Jun (B), respectively. Proteins were separated by
SDS^PAGE and analyzed by autoradiography. The upper panels
display the autophosphorylated kinase (P-Fgr, P-Hck) or the phos-
phorylated substrate (P-GST-c-Jun). In the lower panels an aliquot
of the immunoprecipitates was blotted and probed with speci¢c
antibodies to demonstrate similar amounts of immunoprecipitated
enzyme in each sample. Immunoprecipitations with non-speci¢c
antibodies (n.s.) from JOSK-M cells infected for 30 min with N309
show the speci¢city of the immunoprecipitations. The results indi-
cate that the activation of Src-like tyrosine kinases as well as JNK
upon infection of phagocytes with N. gonorrhoeae depends on the
function of the acid sphingomyelinase. The blots are representative
for three similar experiments. C: Inhibition of Src-like tyrosine ki-
nases using the inhibitor lavendustin (15 min preincubation, 10 WM)
does not in£uence the activation of the acid sphingomyelinase upon
infection of human phagocytic JOSK-M cells with N. gonorrhoeae
N309. The bars represent means þ standard deviation of two experi-
ments with duplicate samples.
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4. Discussion
In the present manuscript we provide evidence for an im-
portant function of the acid sphingomyelinase in the opsonin-
independent, Opa52-mediated internalization of N. gonor-
rhoeae by human phagocytes and, furthermore, in the activa-
tion of CEACAM receptor-triggered signalling pathways.
Imipramine as well as SR33557 blocked Opa52-mediated in-
ternalization. Re-addition of C16-cermide to those cells re-
stored internalization. Since cermide, the only product of
ASM activity, restores internalization of N. gonorrhoeae in
cells treated with the inhibitors, it is very likely that ASM
and ceramide and not other proteins are targeted by the
two inhibitors mediate internalization.
Imipramine has been shown to induce proteolytic degrada-
tion of the acid sphingomyelinase by a still unknown mecha-
nism [14]. SR33557, which is structurally similar to imipra-
mine, acts much faster and without a detectable degradation
of p75 or p72 ASM suggesting that this inhibitor might act in
a di¡erent manner than imipramine. A rapid inhibition of
ASM in JOSK-M cells is consistent with previous studies on
this inhibitor [15].
Our studies add another model system to the growing num-
ber of receptors activating ASM. Those receptors include
CD95, TNF, CD5, CD28, or ICAM [4,16^22]. However, it
is unknown how these receptors increase the activity of the
ASM. Preliminary data from our group show a modi¢cation
of ASM activity by nucleotides, phosphatidylinositol-phos-
phates and even tyrosine phosphorylation in vitro, but it is
unclear whether these factors or modi¢cations are involved in
ASM activation in vivo.
Though the acid sphingomyelinase has been thought to lo-
calize selectively to lysosomes, it has been recently demon-
strated that this enzyme activity is also present in transport
vesicles and can be secreted into the extracellular space [23].
Vesicles containing acid sphingomyelinase may be mobilized
by CEACAM receptor engagement, a process which may lead
to the presence of sphingomyelinase activity at the sites of
bacterial adhesion. There, the acid sphingomyelinase gets ac-
cess to sphingomyelin, which is predominantly located in the
extracellular lea£et of the plasma membrane. Rapid formation
of ceramide by sphingomyelinase activity has been shown to
result in generation of ceramide-rich membrane microdomains
[24]. Glycosphingolipid- and sphingomyelin-enriched mem-
brane domains have been referred to as detergent insoluble
glycolipid-enriched complexes (DIGs) or lipid rafts and they
seem to in£uence the distribution of membrane receptors. Es-
pecially glycosylphosphatidylinositol (GPI)-anchored proteins
and the doubly acylated Src tyrosine kinases have been re-
ported to preferentially partition into DIGs [25,26]. Interest-
ingly, the CEACAM6 receptor, one of the Opa52-binding re-
ceptors that are found on phagocytic cells, possesses a GPI-
anchor. In addition, the Src family kinases Hck and Fgr are
profoundly activated upon CEACAM receptor engagement
by Opa52-expressing bacteria. Therefore, it is conceivable
that the activation of the acid sphingomyelinase and the gen-
eration of ceramide establish speci¢c membrane properties in
the vicinity of the bacteria that ensure a favorable microenvi-
ronment for CEACAM receptor-Src family kinase crosstalk.
In this model, activation of the acid sphingomyelinase would
be a prerequisite for e⁄cient signal transmission and bacterial
internalization, but the enzyme would not be directly involved
in the signalling cascade and rather provide the context for
CEACAM receptor-initiated signalling events. Such a func-
tion of the acid sphingomyelinase would also explain the
fact that the enzyme is not only activated in response to bac-
terial invasion, but also by a whole variety of receptors as
mentioned above. Interestingly, stimulation of acid sphingo-
myelinase activity by these receptors generally is very fast,
pointing to a role for this enzyme in receptor proximal signal-
ling events. Some of these receptors, in particular CD95 and
TNF, trigger apoptosis, which has been suggested to be one of
the major functions of cellular ceramide, however, the major-
ity of these receptors are co-stimulatory or even prevent apop-
tosis. Therefore, a simple connection of the acid sphingo-
myelinase to one particular function such as apoptosis
seems to be unlikely and a role in the translocation of recep-
tors into lipid rafts and/or receptor clustering might explain
the involvement of the enzyme in multiple signalling path-
ways.
Importantly, several studies provide evidence that sphingo-
lipids including ceramide are capable of activating Src-like
tyrosine kinases directly. In particular, synthetic C6-ceramide
has been demonstrated to rapidly activate p56Lck in lympho-
cytes [27]. Therefore, it might be possible that acid sphingo-
myelinase-generated ceramide has several distinct functions in
the internalization process. First, ceramide could help to es-
tablish membrane microdomains that recruit receptors and
Src-like tyrosine kinases, and second, ceramide could directly
stimulate Src-like tyrosine kinases.
It is interesting to note that not only activation, but also an
inhibition of the acid sphingomyelinase can lead to alterations
in the composition of membranes. This in turn could impair
the ability of the pathogens to adhere to the host cell and
therefore explain a reduced internalization upon imipramine
treatment. However, our immuno£uorescence studies indicate
that N. gonorrhoeae still adheres to imipramine-treated cells,
but is not e⁄ciently internalized. In accordance with these
observations, genetic de¢ciency of the acid sphingomyelinase
in ¢broblasts obtained from a Niemann^Pick-patient Type A
almost completely prevents uptake of N. gonorrhoeae but does
not alter the adhesion of the bacteria to those cells [4].
In contrast to the Opa52-positive N. gonorrhoeae N309 and
E. coli H1907, neither the Opa-negative, pili-expressing MS11
variant N280, nor commensal N. cinerea N340 or E. coli
H1887 induced signi¢cant activation of the acid sphingomye-
linase upon interaction with human phagocytes. This indicates
a speci¢c stimulation of the acid sphingomyelinase by the
Opa52-mediated binding to CEACAM receptors. The interac-
tion of bacterial Opa52-protein and CEACAM molecules re-
sults in the e⁄cient, opsonin-independent internalization of
the bacteria by phagocytic cells [10], but the function of this
process in the context of the infection is still elusive. However,
since most gonococci recovered from human volunteers exper-
imentally challenged with Opa-negative N. gonorrhoeae MS11
expressed Opa52 or a homologue [28], it is reasonable to spec-
ulate that the expression of Opa52 by N. gonorrhoeae provides
a selective survival advantage in vivo. Since the cytoplasmic
domain of CEACAM1 contains an ITIM motif known to
associate with the tyrosine phosphatase SHP-1 and, thus, to
mediate inhibitory signals, the engagement of CEACAM re-
ceptors by N. gonorrhoeae may result in a suppression of
certain neutrophil functions [29]. This notion is supported
by the result that overexpression of CEACAM receptors is
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able to suppress tumor growth in a rodent colon carcinoma
model [30] and it has been speculated that the recruitment of
SHP-1 to the CEACAM receptor is responsible for this e¡ect.
However, since SHP-1 activity is downregulated upon Opa52-
mediated stimulation of CEACAM receptors in human
phagocytes, this phosphatase does not seem to contribute to
a negative signaling event in these cells [11]. Further, in both
epithelial and phagocytic cells internalization of the pathogen-
ic gonococci is accompanied by increased JNK activity [4,10].
Since JNK has been implicated in signaling pathways in re-
sponse to stress that impinge on stress-induced cellular apo-
ptosis [31], the activation of this pathway may also provide a
survival advantage for the bacteria.
Finally, it has been recently demonstrated that a gonococcal
outer membrane protein, PorB, translocates into membranes
of eukaryotic cells and interferes with normal phagosome
maturation in primary human phagocytes [32]. Intimate at-
tachment of Opa52-expressing bacteria to CEACAM recep-
tor-rich membrane microdomains may enable the transloca-
tion of PorB into host cell membranes and prevent maturation
of the newly formed phagosomes to mature lysosomes. In
addition, CEACAM receptor-mediated uptake may target
the pathogen to a di¡erent intracellular compartment than
bacteria phagocytosed via opsonin-dependent mechanisms.
This may permit the intracellular bacteria to survive for pro-
longed times. Future studies on the intracellular accommoda-
tion of Opa52-expressing bacteria following CEACAM recep-
tor-mediated internalization should help in elucidating the
intracellular survival strategy of these pathogens.
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